- Adult Stem Cell
- Human Embryonic Cell
- Pluripotent Stem Cell
- Others
The global stem cells market is projected to reach USD 403 million by 2027 from USD 185 million in 2020, at a CAGR of 16.9% during the forecast period owing to increase in prevalence of target chronic diseases and higher adoption of technological advancements coupled with rise in the economy and per capita expenditure are expected to drive the growth of the market. Moreover, rising investments in R&D owing to increased demand for stem cell production for potential investigation in disease management and cellular therapies are also recognized as the next major advancements in transforming healthcare. Additionally, Market players are expanding their cellular therapy portfolio understanding the future potential of the segment which fuels the growth of the market. However, expensive procedures for the development of stem cell therapies and regulatory complications restrains the growth of the market. Global stem cells market is surging due to increased approvals and strategic collaborations among the market players to strengthen their position different regions of the globe. For instance, In April 2018, Pluristem Therapeutics Inc., a developer of placenta based stem cell products announced that the U.S.FDA has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event. In September 2017, Pluristem Therapeutics Inc. has announced that the company has issued two new patients by Hong Kong Patents Registry for its cell therapy products relating to two of the company’s leading indications, Critical Limb Ischemia (CLI) and muscle regeneration.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Scientists are involved in discovering novel methods in creating human stem cells owing to rising demand for the stem cell production. For instance, in March 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells†from a cellular trash pile. This novel discoveries in stem cell therapies are recognized as the major advancements in the transformation of healthcare. Support of the government in discovering stem cells and the increase in number of stem cell banks are expected to fuel the growth of the market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.